Next 10 |
GTB-3650 Phase 1 trial initiation expected in H2 2024; initial clinical data expected in H1 2025 GTB-5550 TriKE ® IND submission for treatment of B7H3 positive solid tumors expected in Q1 2025 GTB-5550 Phase 1 dose escalation basket trial initiation expected in 20...
2024-06-20 14:11:25 ET More on GT Biopharma Financial information for GT Biopharma Read the full article on Seeking Alpha For further details see: GT Biopharma files to sell 740,000 shares by holders
2024-05-22 10:00:31 ET More on etc. Replimune: Continuing To Justify The Bear Thesis (For Now) Gold At $3,000 Is The Wrong Way To Think About The Precious Metal Best Buy: Poised For Growth Amid E-Commerce Threat Nvidia’s upcoming earnings has investors...
2024-05-22 08:18:07 ET Losers: Edible Garden AG ( EDBL ) -32% . LifeStance Health Group LFST -20% on prices secondary offering at $6.25 per share . FLJ Group Ltd ( FLJ ) -17% . Borealis Foods ( BRLS ) -17% . Cheetah Net Supply Chain Serv...
2024-05-21 11:08:14 ET More on GT Biopharma Seeking Alpha’s Quant Rating on GT Biopharma Historical earnings data for GT Biopharma Financial information for GT Biopharma Read the full article on Seeking Alpha For further details see: GT Bio...
2024-05-21 10:00:13 ET More on Health Care Select Sector SPDR XLV: Healthcare Is Ripe For Buying, Despite Patent Cliff XLV: Pivotal Week Of Earnings For Healthcare Stocks XLV: Fundamentals Don't Support Overweighting Health Care Short interest in S&P 500 ...
BRISBANE, CALIFORNIA, May 21, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (NASDAQ: GTBP) (the “Company”), today announced that it has entered into a definitive securities purchase agreements for the purchase and sale of 740,000 shares of the Company’s common stock at a purcha...
A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 16.4% to $0.199 on volume of 720,586,242 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 74.8% to $1.8 on volume of 682,362,254 shares Pineapple Energy Inc. (PEGY) rose 80.3% to $0.1...
2024-05-20 13:12:18 ET More on mid-day movers & stocks. CervoMed: H2 2024 Data For DLB Program A Major Inflection Point Scorpius gains on cGMP facility validation for microbial manufacturing Scorpius prices public offering of units to raise $6M Historical...
2024-05-20 10:43:46 ET GT Biopharma Inc (NASDAQ: GTBP) is up a whopping 150% at writing even though there hasn’t been any news to catalyse that sort of a rally in shares of the clinical-stage biopharmaceutical company. GT Biopharma stock trading volume today $GTBP did not...
News, Short Squeeze, Breakout and More Instantly...
GTB-3650 Phase 1 trial initiation expected in H2 2024; initial clinical data expected in H1 2025 GTB-5550 TriKE ® IND submission for treatment of B7H3 positive solid tumors expected in Q1 2025 GTB-5550 Phase 1 dose escalation basket trial initiation expected in 20...
BRISBANE, CALIFORNIA, May 21, 2024 (GLOBE NEWSWIRE) -- GT Biopharma, Inc. (NASDAQ: GTBP) (the “Company”), today announced that it has entered into a definitive securities purchase agreements for the purchase and sale of 740,000 shares of the Company’s common stock at a purcha...
A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 16.4% to $0.199 on volume of 720,586,242 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 74.8% to $1.8 on volume of 682,362,254 shares Pineapple Energy Inc. (PEGY) rose 80.3% to $0.1...